What is the Role of Technological Advancements in Growth of BPH Procedures?
According to a report by P&S Intelligence, the benign prostatic hyperplasia (BPH) procedures are predicted to advance at a 2.3% CAGR during 2017–2023. The enlargement of the prostate gland is referred to as BPH. The prostate surrounds the urethra, which is the tube that carries urine from the bladder out of the body. The growth of the prostate gland may squeeze or partly block the urethra, which can cause problems while urinating.
Apart from this, the ambulatory surgical centers category is predicted to advance at the fastest pace during the forecast period, as the inflow of BPH patients is rising in these medical settings. The development of technologically innovative procedures is resulting in the rising number of patients in ambulatory surgical centers. Geographically, Europe accounted for the largest number of BPH procedures in the past. The lower cost of BPH treatment in comparison to the U.S., increasing aging population, high healthcare spending are driving the growth of the regional market.
A key trend being witnessed in the BPH procedures is the technological advancements in the BPH treatment due to the high number of outpatient procedures. The utilization of minimally invasive procedures, including laser-based treatments, has risen considerably owing to technological advancements in urology. Several treatment methods, including the utilization of pulsed electromagnetic field therapy and Rezum system, are being developed for treating BPH. Dr Allen’s device is one other technologically advanced BPH treatment devices.
Hence, the BPH procedures are being driven by the rising prevalence of BPH and technological advancements in the domain.
Source: P&S Intelligence
The nerve repair and regeneration market is expect ...
The European Union (EU) point-of-care ultrasound ( ...
You have no groups that fit your search